Teleflex Incorporated (NYSE: TFX) has announced the enrollment of the first patient in the DUBSTENT DIABETES trial, a new clinical study designed to evaluate whether combining two ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PCI improved angina symptoms at 12 weeks vs. a sham ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) experienced lower rates of both thrombotic and bleeding events than those ...

Please provide your email address to receive an email when new articles are posted on . Among patients with diabetes, those taking a GLP-1 had better 3-year survival rates after PCI for a heart attack ...